No guidance ?? The addressable market looks pretty massive to me and now with CE mark , RHT will be re rated worth in the $billions!
With an estimated global prevalence of between 24-30%1 , NAFLD affects up to 2.3 billion people, a figure expected to grow year-on-year. Of these, about 470 million people (or 20%) will develop NASH2 .
Ann: HepaFat-AI Receives TGA Approval, page-45
Add RHT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.8¢ |
Change
-0.002(3.33%) |
Mkt cap ! $25.91M | |||
| Open | High | Low | Value | Volume |
| 5.9¢ | 5.9¢ | 5.8¢ | $9.735K | 166.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 5.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.0¢ | 100541 | 2 |
View Market Depth
| Last trade - 13.54pm 07/10/2024 (20 minute delay) ? |
| RHT (ASX) Chart |